JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.84T
| $22.3B | 2.94% |
93,021,058
+275,734
| +0.3% | +$66.2M |
2013 Q2
38 quarters
|
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $20.8B | 2.74% |
54,319,105
-2,679,475
| -5% | -$1.03B |
2013 Q2
38 quarters
|
|
3
Apple
AAPL
$4.87T
| $16.7B | 2.2% |
128,268,377
+4,643,920
| +4% | +$664M |
2013 Q2
38 quarters
|
|
4
UnitedHealth
UNH
$334B
| $11.9B | 1.57% |
22,474,986
+130,971
| +0.6% | +$69.4M |
2013 Q2
38 quarters
|
|
5
AbbVie
ABBV
$464B
| $9.84B | 1.3% |
60,910,214
+2,431,205
| +4% | +$373M |
2013 Q2
38 quarters
|
|
|
6
Amazon
AMZN
$2.71T
| $9.62B | 1.27% |
114,501,258
+13,991,872
| +14% | +$1.38B |
2013 Q2
38 quarters
|
|
7
Vanguard Total International Bond ETF
BNDX
$82.3B
| $9.38B | 1.24% |
197,807,790
-12,622,452
| -6% | -$608M |
2015 Q1
31 quarters
|
|
8
Bristol-Myers Squibb
BMY
$125B
| $7.1B | 0.94% |
98,663,476
-834,677
| -0.8% | -$62.9M |
2013 Q2
38 quarters
|
|
9
ConocoPhillips
COP
$152B
| $6.92B | 0.91% |
58,686,230
+4,943,607
| +9% | +$601M |
2013 Q2
38 quarters
|
|
10
Vanguard Total Bond Market
BND
$158B
| $6.79B | 0.9% |
94,508,035
+6,935,497
| +8% | +$497M |
2013 Q2
38 quarters
|
|
11
Alphabet (Google) Class C
GOOG
$4.16T
| $6.26B | 0.83% |
70,597,306
-7,012,374
| -9% | -$669M |
2013 Q2
38 quarters
|
|
12
Mastercard
MA
$484B
| $5.97B | 0.79% |
17,168,199
+496,480
| +3% | +$163M |
2013 Q2
38 quarters
|
|
13
ExxonMobil
XOM
$674B
| $5.88B | 0.78% |
53,325,975
+3,478,982
| +7% | +$373M |
2013 Q2
38 quarters
|
|
14
Eli Lilly
LLY
$1.02T
| $5.86B | 0.77% |
16,019,661
+1,261,226
| +9% | +$447M |
2013 Q2
38 quarters
|
|
15
NextEra Energy
NEE
$160B
| $5.75B | 0.76% |
68,722,896
+5,996,497
| +10% | +$484M |
2013 Q2
38 quarters
|
|
|
16
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $5.71B | 0.75% |
14,942,400
+352,800
| +2% | +$136M |
2013 Q2
38 quarters
|
|
17
Deere & Co
DE
$185B
| $5.7B | 0.75% |
13,287,600
+317,832
| +2% | +$129M |
2013 Q2
38 quarters
|
|
18
Johnson & Johnson
JNJ
$617B
| $5.59B | 0.74% |
31,662,477
+1,530,390
| +5% | +$264M |
2013 Q2
38 quarters
|
|
|
19
Alphabet (Google) Class A
GOOGL
$4.2T
| $5.56B | 0.73% |
62,967,428
-2,940,660
| -4% | -$279M |
2015 Q4
28 quarters
|
|
|
20
PUT
Invesco QQQ Trust
QQQ
$503B
| $5.43B | 0.72% |
20,389,600
+4,020,500
| +25% | +$1.11B |
2014 Q2
34 quarters
|
|
21
JPMorgan BetaBuilders Japan ETF
BBJP
$19.9B
| $5.29B | 0.7% |
117,811,744
-1,058,814
| -0.9% | -$46.5M |
2018 Q2
18 quarters
|
|
22
Coca-Cola
KO
$369B
| $5.11B | 0.67% |
80,402,895
+1,245,370
| +2% | +$75.2M |
2013 Q2
38 quarters
|
|
23
Bank of America
BAC
$376B
| $4.7B | 0.62% |
141,760,905
+13,038,377
| +10% | +$449M |
2013 Q2
38 quarters
|
|
24
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
| $4.48B | 0.59% |
78,170,499
-1,319,282
| -2% | -$76.1M |
2018 Q3
17 quarters
|
|
25
Regeneron Pharmaceuticals
REGN
$75.7B
| $4.41B | 0.58% |
6,109,545
+403,676
| +7% | +$298M |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.